Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kumi Tominaga"'
Publikováno v:
Veterinary Medicine: Research and Reports. 10:29-35
Background Since astaxanthin (ASX) has potent anti-oxidative effects with inhibitory action of lipid peroxidation and singlet oxygen quenching activity, it is widely used as a functional food for keeping good health in human. Obesity is a risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39031f4b71e93222511cb56f9c756c36
https://doi.org/10.2147/vmrr.s186202
https://doi.org/10.2147/vmrr.s186202
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Astaxanthin, a natural antioxidant, exists in non-esterified and esterified forms. Although it is known that astaxanthin can improve exercise endurance and cause metabolic improvement in skeletal muscle, the effects of the two different forms are unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e38a193f8d484038c349081bc372be4
http://europepmc.org/articles/PMC5874239
http://europepmc.org/articles/PMC5874239
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Astaxanthin is a carotenoid with potent antioxidant and anti-inflammatory activity. To evaluate the anti-inflammatory effect of astaxanthin on skin deterioration, we confirmed its role in epidermal-dermal interactions in vitro. Astaxanthin treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f9da829d5b33d823a4b25063eed510
https://doi.org/10.3164/jcbn.17-35
https://doi.org/10.3164/jcbn.17-35
Publikováno v:
The FASEB Journal. 28
Recently, astaxanthin has been reported to have the cosmeceutical benefits for human skin. To investigate the mechanism of action we examined the effects of astaxanthin on the UVB-induced production of inflammatory cytokines and mediators in human ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c80a7849902ec5ae259a187d2ed2645e
https://doi.org/10.1096/fasebj.28.1_supplement.645.2
https://doi.org/10.1096/fasebj.28.1_supplement.645.2
Publikováno v:
Nippon Eiyo Shokuryo Gakkaishi. 50:429-437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df3a79596bb7dae6eef59b6f4e0673c0
https://doi.org/10.4327/jsnfs.50.429
https://doi.org/10.4327/jsnfs.50.429
Publikováno v:
Acta Biochimica Polonica. 59
Two human clinical studies were performed. One was an open-label non-controlled study involving 30 healthy female subjects for 8 weeks. Significant improvements were observed by combining 6 mg per day oral supplementation and 2 ml (78.9 μM solution)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4175aae4a6262b3deebca655ab7f84b
https://doi.org/10.18388/abp.2012_2168
https://doi.org/10.18388/abp.2012_2168
Autor:
Toshihisa Komori, Kenji Deguchi, Hideshi Yagi, Kumi Tominaga, Roderick T. Bronson, Tatsuro Matsunashi, Yoshihiko Tani, Koichi Sasaki, Tadamitsu Kishimoto
Core binding factor beta (CBF beta) is considered to be a transcriptional coactivator that dimerizes with transcription factors core binding factor alpha 1 (CBFA1), -2, and -3, and enhances DNA binding capacity of these transcription factors. CBF bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02bb246677311a4510ec5d018859ce6
https://europepmc.org/articles/PMC37996/
https://europepmc.org/articles/PMC37996/
